These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20519340)

  • 1. Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin.
    Amundsen R; Christensen H; Zabihyan B; Asberg A
    Drug Metab Dispos; 2010 Sep; 38(9):1499-504. PubMed ID: 20519340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus.
    Lemahieu WP; Hermann M; Asberg A; Verbeke K; Holdaas H; Vanrenterghem Y; Maes BD
    Am J Transplant; 2005 Sep; 5(9):2236-43. PubMed ID: 16095503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin.
    Niessen J; Jedlitschky G; Grube M; Bien S; Schwertz H; Ohtsuki S; Kawakami H; Kamiie J; Oswald S; Starke K; Strobel U; Siegmund W; Rosskopf D; Greinacher A; Terasaki T; Kroemer HK
    Drug Metab Dispos; 2009 May; 37(5):1129-37. PubMed ID: 19237515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.
    Varma MV; Rotter CJ; Chupka J; Whalen KM; Duignan DB; Feng B; Litchfield J; Goosen TC; El-Kattan AF
    Mol Pharm; 2011 Aug; 8(4):1303-13. PubMed ID: 21710988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
    Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.
    Choi MK; Shin HJ; Choi YL; Deng JW; Shin JG; Song IS
    Xenobiotica; 2011 Jan; 41(1):24-34. PubMed ID: 20946088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro.
    Amundsen R; Åsberg A; Ohm IK; Christensen H
    Drug Metab Dispos; 2012 Apr; 40(4):655-61. PubMed ID: 22205779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart.
    Grube M; Köck K; Oswald S; Draber K; Meissner K; Eckel L; Böhm M; Felix SB; Vogelgesang S; Jedlitschky G; Siegmund W; Warzok R; Kroemer HK
    Clin Pharmacol Ther; 2006 Dec; 80(6):607-20. PubMed ID: 17178262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
    Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental and Modeling Evidence Supporting the
    Izumi S; Nozaki Y; Lee W; Sugiyama Y
    Drug Metab Dispos; 2022 May; 50(5):541-551. PubMed ID: 35241487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients.
    Taylor PJ; Kubler PA; Lynch SV; Allen J; Butler M; Pillans PI
    Ann Pharmacother; 2004 Feb; 38(2):205-8. PubMed ID: 14742751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic uptake of atorvastatin: influence of variability in transporter expression on uptake clearance and drug-drug interactions.
    Vildhede A; Karlgren M; Svedberg EK; Wisniewski JR; Lai Y; Norén A; Artursson P
    Drug Metab Dispos; 2014 Jul; 42(7):1210-8. PubMed ID: 24799396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein.
    Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting inhibitory effects of cyclosporin A, but not tacrolimus, on OATP1B1- and OATP1B3-mediated uptake.
    Shitara Y; Takeuchi K; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
    Drug Metab Pharmacokinet; 2012; 27(4):368-78. PubMed ID: 22240838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.
    Shitara Y; Itoh T; Sato H; Li AP; Sugiyama Y
    J Pharmacol Exp Ther; 2003 Feb; 304(2):610-6. PubMed ID: 12538813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preincubation-dependent and long-lasting inhibition of organic anion transporting polypeptide (OATP) and its impact on drug-drug interactions.
    Shitara Y; Sugiyama Y
    Pharmacol Ther; 2017 Sep; 177():67-80. PubMed ID: 28249706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins.
    Sharma P; Butters CJ; Smith V; Elsby R; Surry D
    Eur J Pharm Sci; 2012 Aug; 47(1):244-55. PubMed ID: 22538052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the antiviral drug telaprevir with renal and hepatic drug transporters.
    Kunze A; Huwyler J; Camenisch G; Gutmann H
    Biochem Pharmacol; 2012 Oct; 84(8):1096-102. PubMed ID: 22902721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.
    Chen C; Mireles RJ; Campbell SD; Lin J; Mills JB; Xu JJ; Smolarek TA
    Drug Metab Dispos; 2005 Apr; 33(4):537-46. PubMed ID: 15616150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.